Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2009-05-12 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LUNEL (34400), Herault
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE PRINCIPALE : revenue, balance sheet and financial ratios
PHARMACIE PRINCIPALE is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LUNEL (34400),
this company of category PME
shows in 2024 a net income positive of 234 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE PRINCIPALE (SIREN 512357989)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
234 433 €
354 321 €
219 487 €
185 977 €
137 649 €
152 031 €
111 986 €
-314 120 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE PRINCIPALE generates positive net income of 234 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
234 433 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 174%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
173.681%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
33.582%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE PRINCIPALE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
474.947
349.453
241.852
235.199
176.275
134.734
127.544
173.681
Financial autonomy
14.757
19.193
25.481
26.78
32.365
36.926
40.301
33.582
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
173.682024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average+11 pts over 3 years
In 2024, the debt ratio of PHARMACIE PRINCIPALE (173.68) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
33.58%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average-6 pts over 3 years
In 2024, the financial autonomy of PHARMACIE PRINCIPALE (33.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 252.20. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
252.196
Liquidity indicators evolution PHARMACIE PRINCIPALE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
101.443
100.327
93.795
218.626
205.849
181.42
228.021
252.196
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
252.22024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good+31 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE PRINCIPALE (252.20) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE PRINCIPALE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE PRINCIPALE is estimated at
3 272 857 €
(range 2 279 166€ - 4 896 382€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2279k€3272k€4896k€
3 272 857 €Range: 2 279 166€ - 4 896 382€
NAF 5 année 2024
Valuation method used
Net Income Multiple
234 433 €
×
14.0x
=3 272 858 €
Range: 2 279 167€ - 4 896 383€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE PRINCIPALE with other companies in the same sector:
Frequently asked questions about PHARMACIE PRINCIPALE
What is the revenue of PHARMACIE PRINCIPALE ?
The revenue of PHARMACIE PRINCIPALE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE PRINCIPALE profitable?
Yes, PHARMACIE PRINCIPALE generated a net profit of 234 k€ in 2024.
Where is the headquarters of PHARMACIE PRINCIPALE ?
The headquarters of PHARMACIE PRINCIPALE is located in LUNEL (34400), in the department Herault.
Where to find the tax return of PHARMACIE PRINCIPALE ?
The tax return of PHARMACIE PRINCIPALE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE PRINCIPALE operate?
PHARMACIE PRINCIPALE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart